CINECA IRIS Institutional Research Information System

D'AGOSTINO, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.485
NA - Nord America 1.238
EU - Europa 460
SA - Sud America 249
AF - Africa 53
OC - Oceania 2
Totale 3.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.185
SG - Singapore 587
CN - Cina 384
IT - Italia 257
HK - Hong Kong 214
BR - Brasile 210
VN - Vietnam 91
KR - Corea 57
JP - Giappone 46
DE - Germania 38
IN - India 29
CA - Canada 22
GB - Regno Unito 22
MA - Marocco 22
FI - Finlandia 20
FR - Francia 20
MX - Messico 18
CH - Svizzera 16
IQ - Iraq 15
AT - Austria 14
AR - Argentina 12
NL - Olanda 10
TR - Turchia 10
ZA - Sudafrica 10
BD - Bangladesh 9
EC - Ecuador 8
ES - Italia 8
PL - Polonia 8
SE - Svezia 8
RO - Romania 7
DZ - Algeria 6
IE - Irlanda 6
PK - Pakistan 6
RU - Federazione Russa 6
TN - Tunisia 6
VE - Venezuela 6
PY - Paraguay 5
UA - Ucraina 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CR - Costa Rica 4
EG - Egitto 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
PH - Filippine 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
MD - Moldavia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
HN - Honduras 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
LV - Lettonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SO - Somalia 1
SV - El Salvador 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 3.487
Salva come PNG Salva come JPEG
Città #
Singapore 362
San Jose 253
Hong Kong 204
Santa Clara 182
Ashburn 115
Dallas 102
Shanghai 92
Hefei 88
Seoul 56
Milan 53
Los Angeles 48
New York 47
Tokyo 44
Beijing 40
Boardman 39
Rome 30
Ho Chi Minh City 27
São Paulo 22
Casablanca 20
Chicago 20
Council Bluffs 20
Hanoi 18
Pisa 16
Zurich 16
Helsinki 15
Redondo Beach 15
Salt Lake City 13
Lucca 12
Nuremberg 12
Chennai 10
Figino 10
Frankfurt am Main 9
Mexico City 9
Belo Horizonte 8
Brooklyn 8
Denver 8
Livorno 8
Buffalo 7
Elk Grove Village 7
Houston 7
Johannesburg 7
Lauterbourg 7
Munich 7
Orem 7
Phoenix 7
Stockholm 7
Vienna 7
Atlanta 6
Dublin 6
Erbil 6
London 6
Montreal 6
Quito 6
Wuhan 6
Baghdad 5
Brasília 5
Florence 5
Fuzhou 5
Genoa 5
Guangzhou 5
Haiphong 5
Hyderabad 5
Lahore 5
Montecatini Terme 5
Mumbai 5
Palermo 5
Porto Alegre 5
Quanzhou 5
Salvador 5
Tashkent 5
Toronto 5
Târgovişte 5
Warsaw 5
Amsterdam 4
Dhaka 4
Düsseldorf 4
Laghouat 4
Memphis 4
Messina 4
Parma 4
Roubaix 4
Santa Maria 4
Tampa 4
Wilmington 4
Xiamen 4
Ankara 3
Baku 3
Bexley 3
Canoas 3
Changsha 3
Curitiba 3
Da Nang 3
Lancaster 3
Mataró 3
Montevideo 3
Nairobi 3
San Francisco 3
San José 3
Seattle 3
Tunis 3
Totale 2.351
Salva come PNG Salva come JPEG
Nome #
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains 165
8.1.4 – Biological Vesicles and Platforms – Cyclodextrin-based platforms as RNA delivery systems 140
Helicobacter pylori CAs inhibition 137
β-Cyclodextrin nanosponges for the ocular delivery of therapeutic Micro-RNA in a Mouse model of retinitis Pigmentosa: A proof of concept study 127
Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma 112
Antibacterial alkylguanidino ureas: Molecular simplification approach, searching for membrane-based MoA 109
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 99
Structure, Function, and Genetic Variation of CYP2D6, a Cytochrome Metabolizing Drugs 97
Antimicrobial and Antibiofilm Activities of Carvacrol, Amoxicillin and Salicylhydroxamic Acid Alone and in Combination vs. Helicobacter pylori: Towards a New Multi-Targeted Therapy 93
An insight into the last 5-year patents on Porphyromonas gingivalis and Streptococcus mutans, the pivotal pathogens in the oral cavity 92
A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors 91
A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers 89
An update on antibacterial AlkylGuanidino Ureas: Design of new derivatives, synergism with colistin and data analysis of the whole library 89
Benzenesulfonamide decorated dihydropyrimidin(thi)ones: carbonic anhydrase profiling and antiproliferative activity 88
Focused library of phenyl-fused macrocyclic amidinoureas as antifungal agents 87
Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment 82
Benzoimidazotriazinedione: a promising scaffold for ALDH1A selective inhibitors as anticancer agents 77
An updated patent review on monoamine oxidase (MAO) inhibitors 75
Enzyme-mediated activation of prodrugs 74
Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model 73
The challenging inhibition of Aldose Reductase for the treatment of diabetic complications: a 2019–2023 update of the patent literature 69
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization 67
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 67
Demethylation Leading to a Loss of Functional Activity: Searching for a New Target for a Promising Antiproliferative Dipheylimidazo[1,2-a]pyridine Derivative 64
Exploring the Polypharmacological Potential of PCI-27483: A Selective Inhibitor of Carbonic Anhydrases IX and XII 61
Unprecedented carbonic anhydrase inhibition mechanism: Targeting histidine 64 side chain through a halogen bond 61
Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms 59
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 57
Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies 51
Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors 51
Inhibition of Pseudomonas aeruginosa Carbonic Anhydrases, Exploring Ciprofloxacin Functionalization Toward New Antibacterial Agents: An In-Depth Multidisciplinary Study 50
Urease 50
Catechol-O-methyltransferase (COMT) 50
The impact of counterions in biological activity: case study of antibacterial alkylguanidino ureas 48
Emerging compounds and therapeutic strategies to treat infections from Trypanosoma brucei: an overhaul of the last 5-years patents 47
Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action 47
Foreword - Terpenes, Medicinal Chemistry Lessons From Nature 46
Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds 46
A Journey Around Boronic Acids: Sulfonyl Hydrazone-Containing Derivatives as Carbonic Anhydrase Inhibitors 44
Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus Agents 43
Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors 42
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 42
Pegylation Approach Applied to Erlotinib-Carbonic Anhydrase Inhibitors Hybrids Towards Anticancer Agents 40
O-derivatization of natural tropolone and β-thujaplicin leading to effective inhibitors of human carbonic anhydrases IX and XII 40
Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori α‐carbonic anhydrase inhibitors 39
New peptidyl-tailed coumarin derivatives acting as dual monoamine oxidases and carbonic anhydrases inhibitors for a perspective anticancer application 37
Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors 36
Assessment of The Green Corrosion Inhibition Performances of Thymus Algeriensis Microwave-Assisted Extracts on Mild Steel in Acid Solution 36
Identification, synthesis and biological activity of alkyl-guanidine oligomers as potent antibacterial agents 36
Nature-Inspired Compounds: Synthesis and Antibacterial Susceptibility Testing of Eugenol Derivatives against H. pylori Strains 32
Synthesis of linear guazatine derivatives as antibacterial agents 30
From a serendipitous discovery to new alkyl-guanidine oligomers as perspective antibacterial agents 30
Nature-Inspired Antibacterial Agents: Derivatization of Eugenol toward promising anti-H. pylori agents 30
From a serendipitous discovery to new alkyl-guanidine oligomers as perspective antibacterial agents 27
Fluorescent probe: target fishing of novel antifungal macrocyclic compounds 27
AlkylGuanidino Ureas, from a Serendipitous Discovery to a Rational Design: Innovative Membrane-Active Antibacterial Agents 27
From a serendipitous discovery to new alkyl-guanidine oligomers as perspective antibacterial agents 26
null 20
null 16
null 15
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction 15
Hybridization Approach Applied to Umbelliferon and Vanilloids toward New Inhibitors of Carbonic Anhydrases IX and XII with In Vitro Antiproliferative and Anti-inflammatory Activities 14
null 11
null 11
Totale 3.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 0 0 0 0 0 0 1 1 0 0 0 0
2023/2024194 2 0 2 35 38 54 18 3 0 3 6 33
2024/20251.579 71 39 60 52 119 285 96 39 103 123 283 309
2025/20261.978 137 238 195 232 221 105 224 113 127 204 92 90
Totale 3.753